New approach for quantification of left ventricular function from low-dose gated bloodpool SPECT: Validation and comparison with conventional methods in patients

J Nucl Cardiol. 2021 Jun;28(3):939-950. doi: 10.1007/s12350-019-01823-8. Epub 2019 Jul 23.

Abstract

Background: Planar equilibrium radionuclide angiocardiography (ERNA) has been used as the gold standard for assessment of left ventricular (LV) function for over three decades. However, this imaging modality has recently gained less favor due to growing concerns about radiation exposure. We developed a novel approach that involves integrating short axis slices of gated bloodpool SPECT for quantification of LV function with improved signal-to-noise ratio and reduced radioactive dose while maintaining image quality and quantitative precision.

Methods: Twenty patients referred for ERNA underwent standard in vitro 99mTc-labeling of red blood cells (RBC), and were initially imaged following a low-dose (~ 8 mCi) injection using a dedicated cardiac SPECT camera, and then had planar imaging following a high-dose (~ 25 mCi) injection. Four different quantification methods were utilized to assess the LV function and were compared for quantitative precision and inter-observer reproducibility of the quantitative assessments.

Results: The Yale method resulted in the most consistent assessment of LV function compared with the gold standard high-dose ERNA method, along with excellent inter-observer reproducibility.

Conclusions: The new low-dose 99mTc-RBC imaging method provides precise quantification of LV function with a greater than 67% reduction in dose and may potentially improve assessment of regional function.

Keywords: ERNA; Gated bloodpool SPECT; ejection fraction; left ventricular volumes.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography / methods*
  • Coronary Angiography
  • Female
  • Gated Blood-Pool Imaging / methods*
  • Humans
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Radiopharmaceuticals*
  • Reproducibility of Results
  • Sodium Pertechnetate Tc 99m*
  • Stroke Volume
  • Ventricular Dysfunction, Left / diagnostic imaging*
  • Ventricular Dysfunction, Left / physiopathology

Substances

  • Radiopharmaceuticals
  • Sodium Pertechnetate Tc 99m